CollPlant developing Type I Recombinant Human Collagen from Transgenic Tobacco Plants
CollPlant Ltd., a biotechnology company specializing in the development and commercialization of novel medical products based on its plant-derived, Type I collagen and other recombinant proteins, announced that they elected Mr. Ronny Barak as Chief Executive Officer and Director of CollPlant.
Mr. Barak, 40, has been Chief Executive Officer and General Manager of Disc-O-Tech, in Princeton, N.J. USA, since 2005 and prior to that Vice President of Sales & Marketing - Spine. While at Disc-O-Tech, together with the management team, he led the company in signing a successful acquisition transaction with Kyphon/ Medtronic Corp. Prior to Disc-O-Tech, he served as Franchise Development Group Manager- Inter-Continental Division of Boston Scientific and Vice President and Managing Director at A.M.I. Technologies, Ltd in Israel, a medium sized medical device distribution company. He holds a Bachelor of Science degree in Chemistry from the Hebrew University of Jerusalem and a Masters in Business Administration degree specializing in Marketing from The Ramat Gan College in Israel.
Other news from the department people
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
